Tânia Carlice dos Reis

Tânia Carlice dos Reis

Auto-generated profile, based on publicly available information

Tânia Carlice dos Reis

Universidade de Santiago e Universidade Intercontinental de Cabo Verde

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TCTânia Carlice-Dos-Reis
Tânia Carlice-Dos-Reis
JVJaime Viana
Jaime Viana
Fabiano MoreiraFabiano Moreira
Fabiano Moreira
GCGreice De Lemos Cardoso
Greice De Lemos Cardoso
JGJoão Guerreiro
João Guerreiro
ÂRÂndrea Ribeiro-Dos-Santos
Ândrea Ribeiro-Dos-Santos
Mutations in the HBB gene are responsible for several serious hemoglobinopathies, such as sickle cell anemia and β-thalassemia. Sickle cell anemia is one of the most common monogenic diseases worldwide. Due to its prevalence, diverse strategies have been developed for a better understanding of its molecular mechanisms. In silico analysis has been increasingly used to investigate the genotype-phenotype relationship of many diseases, and the sequences of healthy individuals deposited in the 1,000 Genomes database appear to be an excellent tool for such analysis. The objective of this study is to analyze the variations in the HBB gene in the 1,000 Genomes database, to describe the mutation frequencies in the different population groups, and to investigate the pattern of pathogenicity. The computational tool SNPEFF was used to align the data from 2,504 samples of the 1,000 Genomes database with the HG19 genome reference. The pathogenicity of each amino acid change was investigated using the databases CLINVAR, dbSNP and HbVar and five different predictors. Twenty different mutations were found in 209 healthy individuals. The African group had the highest number of individuals with mutations, and the European group had the lowest number. Thus, it is concluded that approximately 8.3% of phenotypically healthy individuals from the 1,000 Genomes database have some mutation in the HBB gene. The frequency of mutated genes was estimated at 0.042, so that the expected frequency of being homozygous or compound heterozygous for these variants in the next generation is approximately 0.002. In total, 193 subjects had a non-synonymous mutation, which 186 (7.4%) have a deleterious mutation. Considering that the 1,000 Genomes database is representative of the world’s population, it can be estimated that fourteen out of every 10,000 individuals in the world will have a hemoglobinopathy in the next generation.

6 July 2022 in Revista Internacional em Língua Portuguesa
Verified
Journal Article
Open access
PDF file
HSHilton Pereira da Silva
Hilton Pereira da Silva
TRTânia Carlice dos Reis
Tânia Carlice dos Reis
KSKeily Silva
Keily Silva
Em janeiro de 2020 a Organização Mundial de Saúde (OMS) identificou uma emergência epidemiológica internacional em decorrência do SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Este artigo apresenta alguns dados disponibilizados em plataformas públicas oficiais sobre a situação da COVID-19, analisa o processo de enfrentamento pelos governos centrais em Cabo Verde e no Brasil e discute como as políticas sociais e de saúde executadas por cada país repercutiram no impacto epidemiológico ao longo do primeiro ano da pandemia, buscando exemplificar como a tomada de decisão sobre a condução das políticas públicas influencia a morbidade e mortalidade nos dois países. Apesar das limitações analíticas em face a uma crise global ainda em andamento, esperamos que este trabalho contribua para ampliar as pesquisas comparativas entre países lusófonos do Cone Sul e para demonstrar a importância da gestão política para o enfrentamento desta doença e das que possam emergir futuramente.